Tocqueville Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Tocqueville Asset Management's BLUE Position: Q3 2019 in Review
Tocqueville Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 374 shares — an estimated $616K sold.
Tocqueville Asset Management first reported a position in BLUE in Q4 2013 and held it in 23 quarters. The position peaked at $8.37M in Q2 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.
- Tocqueville Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
- Tocqueville Asset Management sold 374 bluebird bio shares in Q3 2019, an estimated $616K.
- Tocqueville Asset Management first reported a position in bluebird bio in Q4 2013 and held it in 23 quarters.
- Tocqueville Asset Management's bluebird bio position peaked at $8.37M in Q2 2018.
- 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.
Based on Tocqueville Asset Management's 13F filing for Q3 2019, filed 31 Oct 2019.